← All trials
NCT05283434
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 15, 2021
- Primary completion
- Jun 30, 2023
- Completion date
- Jun 30, 2023
- First posted
- Mar 17, 2022
- Last posted
- Mar 17, 2022
- Enrollment
- 324
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of MinnesotaLead sponsor
- University of MinnesotaOverall official - principal investigator
- University of MinnesotaReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.